Spyro Mousses work email
- Valid
- Valid
- Valid
- Valid
Spyro Mousses personal email
Spyro Mousses phone numbers
Spyro Mousses is a Founder at Oligon, at Oligon. He possess expertise in genomics, lifesciences, oncology, drug discovery, biotechnology and 37 more skills. Colleagues describe him as "Spyro Mousses is a proven visionary whose ideas have directly and deeply influenced how we think about innovation in the Healthcare and Life Sciences. His concepts of "BioIntelligence" and the development of smart systems to enable the widespread practice of genomic medicine have been incorporated into many proposals and movements to make medicine more precise - from the so-called "rapid health learning systems" to the shared data repositories that match patients with the right clinical trials. He is a very rare combination of researcher, clinician, and technologist who can master concepts easily in multiple industries, and more importantly, communicate and lead highly experienced teams in seminal initiatives that prove the validity of his ideas. Those of us who have been fortunate enough to work with him also respect his kindness and empathy for patients and co-workers, and many of us continue to work with him from venture to venture because of his great qualities."
-
Co-FounderOligon Jan 2021 - Present -
CeoSystems Oncology Jul 2015 - PresentScottsdale, Arizona, UsSystems Oncology is a unique biotechnology company, focused on using machine learning and a computational systems biology approach to search, find, acquire, and develop truly innovative therapeutic agents. Our world-class team has the experience and know-how needed to intelligently translate scientific insights into smarter clinical development strategies and faster registration paths. Systems Oncology also has close relationships with multiple leading pharmaceutical partners who can help to rapidly co-develop multiple new cancer drugs in parallel. Taken together, Systems Oncology represents a new model for developing innovative cancer drugs with unprecedented speed, scale, and precision.https://www.systemsoncology.com -
Co-Founder & PresidentSystems Imagination Inc. Jan 2014 - PresentSystems Imagination, Inc. (SII) is a knowledge evolution network company with a mission to make computational intelligence less artificial. We offer unique knowledge computing systems and mass intelligence solutions to mine Big Data and accelerate the discovery, recovery, and evolution of knowledge.
-
Vice President, Office Of Innovation, Professor And Director Of The Center For Biointelligence,Tgen Nov 2002 - Dec 2013Phoenix, Az, UsTGen’s Center for BioIntelligenceMISSION: To re-engineer how we classify complex diseases and thereby provide more detailed and accurate ways to study, understand, differentiate and manage complex medical conditions.The Center for BioIntelligence was formed to develop tools, resources, strategies, and integrated healthcare driven solutions that specifically address this fundamental epistemological problem in how we study and manage disease. Specifically, scientists conducting translational research are greatly hindered by the quantity and quality of clinical data they can access, which is usually limited to very superficial descriptors to classify heterogeneous groups of diseases into a single disease category. This ambiguous disease classification results in fallacious assumptions that undermine the design of translational research studies aimed at discovery and greatly reduces the efficiency and effectiveness of clinical research aimed at advancing new treatments. Importantly, emerging attempts to translate deep genomic/molecular profiling data from individuals towards medically actionable insights (that can be used to guide patient stratification in clinical trials and personalized management of complex diseases) will similarly require the systematic classification based on detailed multidimensional clinical data and mechanistic modeling.TGen’s Office of InnovationTranslating genomics into advances in drug development and health care impact requires sophisticated solutions that integrate disparate technologies, products, services, and resources. TGen’s Office of Innovation is positioned to help envision innovative solutions to unmet needs, and help drive those innovations to the marketplace. Since disparate components from multiple industries are often required to engineer and deploy comprehensive healthcare solutions, the Office of Innovation also works to promote large collaborative initiatives and strategic industry partnerships. -
Director, Pharmaceutical Genomics Division, TgenTgen Nov 2002 - Jan 2010Phoenix, Az, UsWe built the Pharmaceutical Genomics Division at TGen with a focus on developing and applying novel functional genomics methods and high-throughput technologies to identify areas in the human genome that may be vulnerable to drug targets. These unique targets will then be advanced to develop the next generation of molecular medicines. Additionally, new cellular pharmacogenomic strategies have been developed at TGen to discover genes that regulate drug response. These discoveries will be advanced as biomarkers to predict clinical drug response to enable personalized medicine, in other words, getting the right drug to the right patient at the right time.
-
Co-FounderMedtrust Online Jan 2007 - Jan 2012The vision of MedTrust Online is to enable community physicians to practice precision medicine by providing them with tools to treat their patients with the most accurate, individualized medicine.MedTrust Online brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to capture, organize, analyze, integrate and present the most up-to-date medical facts from a vast array of sources. This data is provided to doctors in a comprehensive yet concise way unavailable anywhere else.
-
Founder, Chief Scientific OfficerSystems Medicine Llc A Subsidiary Cell Therapeutics, Inc. Sep 2005 - Jul 2008Seattle, Wa, UsWe founded Systems Medicine with the vision that applying molecular intelligence can greatly accelerate and improve the clinical development of oncology drugs. As CSO, I oversaw the development and implementation of the research strategy for applying the latest genomics technologies to investigate emerging SML oncology drugs. For each drug, the goal is to discover molecular insights that could then be translated for patient stratification or combination strategies to guide more focused clinical trials and more successful clinical development. -
Scientist, National Human Genome Research InstituteNih Sep 1998 - Nov 2002Bethesda, Md, UsDeveloped genomic profiling technology, pharmacogenomics research, high throughput biology platforms
Spyro Mousses Skills
Spyro Mousses Education Details
-
University Of TorontoMolecular Genetics Of Cancer
Frequently Asked Questions about Spyro Mousses
What company does Spyro Mousses work for?
Spyro Mousses works for Oligon
What is Spyro Mousses's role at the current company?
Spyro Mousses's current role is Founder at Oligon,.
What is Spyro Mousses's email address?
Spyro Mousses's email address is sm****@****mac.com
What is Spyro Mousses's direct phone number?
Spyro Mousses's direct phone number is +160265*****
What schools did Spyro Mousses attend?
Spyro Mousses attended University Of Toronto.
What skills is Spyro Mousses known for?
Spyro Mousses has skills like Genomics, Lifesciences, Oncology, Drug Discovery, Biotechnology, Life Sciences, Cancer, Molecular Biology, Drug Development, Clinical Research, Biomarkers, Clinical Trials.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial